COMPANY

Atelerix Life Sciences Inc.

HQ: Indianapolis, IN source · atelerixlifesciences.com ↗ · Midwest

ATELERIX LIFE SCIENCES INC has received NIH funding, most recently in fiscal 2023 for the project “Development of Sudaxine for the Treatment of Opioid Induced Respiratory Depression (OIRD) in the Peri-operative Hospital Setting”. From public records Source · Oct 12, 2026

Keywords: respiratory

Location: Indianapolis, IN · source · Oct 14, 2026

Profile checked Oct 10, 2026

2NIH grants

NIH awards 2

Annual award amounts. Total $1.8M.

Aug 2, 2023 NIH award 5R44HL164201-02 FY2023: $928,464 awarded for that fiscal year; activity R44 (SBIR); PI BATES, JAMES N; recipient as written: ATELERIX LIFE SCIENCES INC., Indianapolis, IN. Development of Sudaxine for the Tr source ↗
Sep 19, 2022 NIH award 1R44HL164201-01A1 FY2022: $908,519 awarded for that fiscal year; activity R44 (SBIR); PI BATES, JAMES N; recipient as written: ATELERIX LIFE SCIENCES INC., Indianapolis, IN. Development of Sudaxine for the source ↗